Literature DB >> 17619666

Pacemaker therapies in cardiology.

Geoffrey Toogood1.   

Abstract

BACKGROUND: Since the first cardiac pacemaker was inserted in 1958 vast changes have occurred in both the technology of the devices and their indications.
OBJECTIVE: This article discusses the indications for pacemakers, currently available devices, insertion procedure, and patient follow up. DISCUSSION: Pacemakers have evolved from simple, single chamber devices to multichambered devices capable of treating not only bradycardias but also tachycardias and heart failure. An international classification has been developed regarding arrhythmias and the benefits of pacemakers. In class I conditions, the benefits of pacemakers are well established, decreasing symptoms and improving prognosis. The most common indications are for patients with symptomatic bradycardia associated with sick sinus syndrome and heart block. Patients need to attend for regular device follow up and be aware of precautions relating to electromagnetic radiation, but this usually involves little disruption to their day-to-day life.

Entities:  

Mesh:

Year:  2007        PMID: 17619666

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

1.  Chemical stimulation of adherent cells by localized application of acetylcholine from a microfluidic system.

Authors:  Susanne Zibek; Britta Hagmeyer; Alfred Stett; Martin Stelzle
Journal:  Front Neuroeng       Date:  2010-11-26

2.  Permanent cardiac pacing in pediatric patients.

Authors:  Wael Lotfy; Ranya Hegazy; Osama AbdElAziz; Rodina Sobhy; Hossam Hasanein; Fawzan Shaltout
Journal:  Pediatr Cardiol       Date:  2012-08-12       Impact factor: 1.655

3.  Effect of anxiety and depression on the fatigue of patients with a permanent pacemaker.

Authors:  Maria Polikandrioti; Konstantinos Tzirogiannis; Sofia Zyga; Ioannis Koutelekos; Georgios Vasilopoulos; Paraskevi Theofilou; George Panoutsopoulos
Journal:  Arch Med Sci Atheroscler Dis       Date:  2018-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.